A new MI risk factor emerges, ASCVD guidelines challenged, and more
Nov 02, 2018•8 min
Episode description
Today, an analysis that may challenge ASCVD guidelines, a new formula may predict adverse events from NSAIDs, a potentially important myocardial infarction risk factor is identified, and a diabetes drug gets a new cardiovascular indication.
For the best experience, listen in Metacast app for iOS or Android
